Overview of QQ3 2025 performance with YoY and QoQ context where available:
- Revenue: Not disclosed in the QQ3 2025 income statement; cost of revenue recorded at $75,000 with gross loss of $75,000, implying either minimal or unrecorded revenue for the period.
- Gross Profit/Loss: -$75,000; Gross margin not defined due to revenue non-disclosure.
- Operating Expenses: $184,498 in the QQ3 period, driving total operating expenses to $259,498 when including cost of revenue and other operating costs.
- EBITDA: -$536,548 (negative).
- Operating Income: -$259,498 (negative). This represents a QoQ and YoY deterioration in operating profitability given the fixed cost base.
- Net Income: -$639,212, EPS -$0.0031. YoY and QoQ deteriorations in profitability are evident: YoY operating income is down approximately 246.6%, and YoY net income is down roughly 628.5%; QoQ declines in operating income and net income are approximately -26.8% and -40.8% respectively.
- EPS (Diluted): -$0.0031.
- Weighted Avg Shares (outstanding): 206,332,426.
- Cash Flow: Net cash provided by operating activities = -$293,240. Free cash flow = -$293,240. Net change in cash = $2,767; cash at end of period = $15,686.
- Balance Sheet health: Total assets $1,631,686; total current assets $15,686; total current liabilities $1,051,067; cash and equivalents $15,686; intangible assets $1,615,000; total liabilities $1,051,067; total stockholders’ equity $580,619; Retained earnings negative at -$6,516,565; short-term debt $667,655; net debt $651,969.
- Key liquidity and leverage ratios: current ratio 0.0149; quick ratio 0.0149; debt ratio 0.409; debt to equity 1.150; price to book 3.48; enterprise value multiple -4.98. Negative earnings support a highly speculative risk profile despite some relatively modest book value signals.